Ripretinib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ripretinib, covering 2025-03-03 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib [Phase 3]